Tenax Therapeutics

NEWS

Business

BioSpace Movers & Shakers, Feb. 4

Biopharma and life sciences companies strengthen their boards and leadership teams with these Movers & Shakers.

February 3, 2022

9 min read

Alex Keown

Business

New CEOs Named at Two Biopharma Companies

Scorpion Therapeutics announced its new CEO Dr. Axel Hoos while Tenax Therapeutics named Christopher Giordano as its new chief executive.

July 8, 2021

2 min read

Vanessa Doctor, RN

IN THE PRESS

Bio NC

FDA Lifts Clinical Hold On Oxygen Biotherapeutics, Inc.'s Program

March 31, 2014

2 min read

Bio NC

Oxygen Biotherapeutics, Inc. Announces Proposed Public Offering

March 18, 2014

1 min read

Bio NC

Oxygen Biotherapeutics, Inc. Prices $52 Million Underwritten Offering

March 18, 2014

3 min read

Drug Development

Oxygen Biotherapeutics, Inc. Rockets As FDA Lifts Hold On Brain Injury Drug Oxycyte

March 4, 2014

1 min read

Drug Development

Oxygen Biotherapeutics, Inc. Release: Newly Published Cardiac Surgery Study Provides Further Evidence That Levosimendan Significantly Improves Post-Operative Kidney Function

February 13, 2014

1 min read

BioCapital

Oxygen Biotherapeutics, Inc. To Present At Two Upcoming Healthcare Investor Conferences

January 7, 2014

1 min read

Drug Development

Oxygen Biotherapeutics, Inc. Announces Key Details Of Phase 3 Trial Protocol For Levosimendan

January 6, 2014

1 min read

Business

Oxygen Biotherapeutics, Inc. Provides A Business Review And Update In Conjunction With Filing Of Second Quarter Fiscal Year 2014 Financials

December 19, 2013

1 min read

Business

Oxygen Biotherapeutics, Inc. Selects Duke Clinical Research Institute To Conduct Phase 3 Trial Of Levosimendan

December 11, 2013

1 min read

BioCapital

Oxygen Biotherapeutics, Inc. To Host 2013 Annual Meeting Of Shareholders

December 4, 2013

1 min read

JOBS